Filling in the GAPs in understanding RAS

被引：2

作者：

Cox, Adrienne D. ^{[1
,2
,3
]}

Der, Channing J. ^{[1
,3
]}

机构：

[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[2] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27515 USA

[3] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA

来源：

SCIENCE | 2021年 / 374卷 / 6564期

关键词：

D O I：

10.1126/science.abl3639

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：152 / 153

页数：2

共 9 条

[1] Acquired Resistance to KRASG12C Inhibition in Cancer [J].

Awad, M. M. ;

Liu, S. ;

Rybkin, I. I. ;

Arbour, K. C. ;

Dilly, J. ;

Zhu, V. W. ;

Johnson, M. L. ;

Heist, R. S. ;

Patil, T. ;

Riely, G. J. ;

Jacobson, J. O. ;

Yang, X. ;

Persky, N. S. ;

Root, D. E. ;

Lowder, K. E. ;

Feng, H. ;

Zhang, S. S. ;

Haigis, K. M. ;

Hung, Y. P. ;

Sholl, L. M. ;

Wolpin, B. M. ;

Wiese, J. ;

Christiansen, J. ;

Lee, J. ;

Schrock, A. B. ;

Lim, L. P. ;

Garg, K. ;

Li, M. ;

Engstrom, L. D. ;

Waters, L. ;

Lawson, J. D. ;

Olson, P. ;

Lito, P. ;

Ou, S. -H. I. ;

Christensen, J. G. ;

Janne, P. A. ;

Aguirre, A. J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (25) :2382-2393

[2] The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients [J].

Hallin, Jill ;

Engstrom, Lars D. ;

Hargis, Lauren ;

Calinisan, Andrew ;

Aranda, Ruth ;

Briere, David M. ;

Sudhakar, Niranjan ;

Bowcut, Vickie ;

Baer, Brian R. ;

Ballard, Joshua A. ;

Burkard, Michael R. ;

Fell, Jay B. ;

Fischer, John P. ;

Vigers, Guy P. ;

Xue, Yaohua ;

Gatto, Sole ;

Fernandez-Banet, Julio ;

Pavlicek, Adam ;

Velastagui, Karen ;

Chao, Richard C. ;

Barton, Jeremy ;

Pierobon, Mariaelena ;

Baldelli, Elisa ;

Patricoin, Emanuel F., III ;

Cassidy, Douglas P. ;

Marx, Matthew A. ;

Rybkin, Igor I. ;

Johnson, Melissa L. ;

Ou, Sai-Hong Ignatius ;

Lito, Piro ;

Papadopoulos, Kyriakos P. ;

Janne, Pasi A. ;

Olson, Peter ;

Christensen, James G. .

CANCER DISCOVERY, 2020, 10 (01) :54-71

[3] The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS [J].

Li, Chuanchuan ;

Vides, Alberto ;

Kim, Dongsung ;

Xue, Jenny Y. ;

Zhao, Yulei ;

Lito, Piro .

SCIENCE, 2021, 374 (6564) :197-+

[4] Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism [J].

Lito, Piro ;

Solomon, Martha ;

Li, Lian-Sheng ;

Hansen, Rasmus ;

Rosen, Neal .

SCIENCE, 2016, 351 (6273) :604-608

[5] Regulator of G-protein signaling (RGS) proteins as drug targets: Progress and future potentials [J].

O'Brien, Joseph B. ;

Wilkinson, Joshua C. ;

Roman, David L. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2019, 294 (49) :18571-18585

[6] K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions [J].

Ostrem, Jonathan M. ;

Peters, Ulf ;

Sos, Martin L. ;

Wells, James A. ;

Shokat, Kevan M. .

NATURE, 2013, 503 (7477) :548-+

[7] Drugging RAS: Know the enemy [J].

Papke, Bjoern ;

Der, Channing J. .

SCIENCE, 2017, 355 (6330) :1158-1163

[8] Clinical Acquired Resistance to KRASG12C Inhibition through a novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation [J].

Tanaka, Noritaka ;

Lin, Jessica J. ;

Li, Chendi ;

Ryan, Meagan B. ;

Zhang, Junbing ;

Kiedrowski, Lesli A. ;

Michel, Alexa G. ;

Syed, Mohammed U. ;

Fella, Katerina A. ;

Sakhi, Mustafa ;

Baiev, Islam ;

Juric, Dejan ;

Gainor, Justin F. ;

Klempner, Samuel J. ;

Lennerz, Jochen K. ;

Siravegna, Giulia ;

Bar-Peled, Liron ;

Hata, Aaron N. ;

Heist, Rebecca S. ;

Corcoran, Ryan B. .

CANCER DISCOVERY, 2021, 11 (08) :1913-1922

[9] A CYTOPLASMIC PROTEIN STIMULATES NORMAL N-RAS P21 GTPASE, BUT DOES NOT AFFECT ONCOGENIC MUTANTS [J].

TRAHEY, M ;

MCCORMICK, F .

SCIENCE, 1987, 238 (4826) :542-545

← 1 →